Gc-MAF is an immune system-supporting protein found naturally in the body that activates cells responsible for fighting infection and disease.

Although the antitumor action of the Macrophage-activating factor has been controversial, we believe it still has a significant place among cancer treatments because it may have sufficient potential to kill cancer cells.

Gc-MAF is a protein that in principle works best in those patients who have a low tumor burden and with poorly differentiated cells.


Overall goals of therapy

  • Improves well-being and quality of life.
  • Enhances the effect of other therapies.
  • Repairs the immune system.
  • Increases the amount of monocytes.
  • Increases the maturation rate of dendritic cells, etc.

Although there is a wide and controversial scientific discussion about the efficacy or lack thereof of this drug, we believe that it does play a significant role in our treatments and therefore we have decided to continue using it.

See Sasei Mirai